Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-dependent calcium channel gamma-like subunit (TMEM37) is a transmembrane protein primarily known for its role as an auxiliary subunit of voltage-gated calcium channels, where it is thought to stabilize the channel in the inactivated (closed) state and modulate calcium current when co-expressed with the T-type calcium channel subunit CACNA1G[1][2][4][8][10]. TMEM37 is located in the membrane and is expressed in multiple human tissues[5]. There is no current evidence that it is a direct therapeutic target or that specific drugs interact directly with this subunit. TMEM37 has been implicated in the regulation of calcium ion flow but is not classified as a standalone channel, receptor, or principal drug target[9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent calcium channel gamma-like subunit (TMEM37).